Crystalline forms of (2R,5S,13AR)-8-hydroxy-7,9,-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide | Patent Number 09682084

US 09682084 B2
Application Number14745121
Publication NumberUS 20150366872 A1
Pendency2 years, 2 days
Filled DateJun 19, 2015
Priority DateJun 20, 2014
Publication DateDec 24, 2015
Expiration DateJun 19, 2034
Inventor/ApplicantsKatie Ann Keaton
Vahid Zia
Ernest A. Carra
Irene Chen
Scott E. Lazerwith
ExaminesHABTE, KAHSAY
Art Unit1624
Technology Center1600
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.